Skip to main content

Morgan Stanley Keeps Their Hold Rating on Centene (CNC)

Tipranks - Tipranks - Thu Mar 5, 10:30PM CST

In a report released yesterday, Erin Wright from Morgan Stanley maintained a Hold rating on Centene, with a price target of $45.00.

Claim 70% Off TipRanks Premium

According to TipRanks, Wright is a 5-star analyst with an average return of 14.8% and a 65.35% success rate. Wright covers the Healthcare sector, focusing on stocks such as Humana, Elanco Animal Health, and Option Care Health.

In addition to Morgan Stanley, Centene also received a Hold from TipRanks – OpenAI’s OpenAI Medical – Healthcare Plans in a report issued today. However, on February 25, Truist Financial reiterated a Buy rating on Centene (NYSE: CNC).

See the top stocks recommended by analysts >>

Based on Centene’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $49.73 billion and a GAAP net loss of $1.1 billion. In comparison, last year the company earned a revenue of $40.81 billion and had a net profit of $283 million

Read More on CNC:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).